 Comparative evaluation loracarbef amoxicillin-clavulanate acute otitis media infants children acute otitis media loracarbef experimental carbacephem antibiotic amoxicillin-clavulanate Augmentin approved drug disease Ninety-two evaluable group Middle ear fluid samples culture therapy Haemophilus spp cases pneumococci cases Moraxella catarrhalis cases beta-Lactamase-producing bacteria patients Clinical failure loracarbef-treated patients amoxicillin-clavulanate-treated patient Recurrence acute otitis media common weeks loracarbef treatment patients amoxicillin-clavulanate therapy patients combined failure recurrence loracarbef-treated patients amoxicillin-clavulanate-treated patients Gastrointestinal side effects loracarbef-treated amoxicillin-clavulanate-treated patients Diaper rash common amoxicillin-clavulanate patients loracarbef patients Satisfactory results antibiotics adverse effects common minor